Palatin Technologies (FRA:PTN) FCF Margin %: -112.65% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:PTN Palatin Technologies Inc FRA:PTN
19 GF Score
Price €3.30
! 5 Warning Signs
View Full Analysis

What is Palatin Technologies FCF Margin %?

Palatin Technologies FRA:PTN 19 FCF Margin % is -112.65% as of Mar. 2026. GuruFocus rates FRA:PTN with a GF Score™ of 19/100. The stock has 5 warning signs investors should review. Among 950 Biotechnology companies, Palatin Technologies ranks worse than 54.53% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Palatin Technologies's Free Cash Flow for the three months ended in Mar. 2026 was €-3.82 Mil. Palatin Technologies's Revenue for the three months ended in Mar. 2026 was €3.39 Mil. Therefore, Palatin Technologies's FCF Margin % for the quarter that ended in Mar. 2026 was -112.65%.

As of today, Palatin Technologies's current FCF Yield % is -108.91%.

The historical rank and industry rank for Palatin Technologies's FCF Margin % or its related term are showing as below:

FRA:PTN' s FCF Margin % Range Over the Past 10 Years
Min: -2056.13   Med: -16.84   Max: 34968.64
Current: -116.51

During the past 13 years, the highest FCF Margin % of Palatin Technologies was 34968.64%. The lowest was -2056.13%. And the median was -16.84%.

FRA:PTN's FCF Margin % is ranked worse than
54.53% of 950 companies
in the Biotechnology industry
Industry Median: -81.28 vs FRA:PTN: -116.51

Palatin Technologies FCF Margin % Related Terms

Palatin Technologies FCF Margin % Historical Data

* Premium members only.

The historical data trend for Palatin Technologies's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Palatin Technologies FCF Margin % Chart

Palatin Technologies Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11,976.43 -2,055.72 -612.01 -701.68 0.00

Palatin Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -18.29 -4,146.46 -112.65

FRA:PTN vs LPCN, NCEL, CLRB: FCF Margin % Comparison

For the Biotechnology subindustry, Palatin Technologies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Palatin Technologies FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Palatin Technologies's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Palatin Technologies's FCF Margin % falls into.


FRA:PTN
19GF Score
Palatin Technologies Inc FRA:PTN
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Palatin Technologies FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Palatin Technologies's FCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-18.473/0
= %

Palatin Technologies's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-3.821/3.392
=-112.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -112.65% mean?
Palatin Technologies (FRA:PTN) has a FCF Margin % of -112.65% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Palatin Technologies and its competitors. According to the industry distribution chart, Palatin Technologies ranks #518 out of 950 companies in the Biotechnology industry, placing it in the top 54.5%.
Is Palatin Technologies' FCF Margin % too high?
Palatin Technologies' current FCF Margin % is -112.65%. Based on the distribution chart, Palatin Technologies ranks #518 out of 950 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Palatin Technologies has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Palatin Technologies' FCF Margin % compare to LPCN and NCEL?
According to the Biotechnology industry distribution chart, Palatin Technologies ranks #518 out of 950 companies for FCF Margin %. This places Palatin Technologies in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Palatin Technologies and its competitors. Palatin Technologies's current FCF Margin % is -112.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Palatin Technologies stock overvalued right now?
Palatin Technologies (FRA:PTN) has a current FCF Margin % of -112.65%. The current FCF Margin % is -112.65%. Palatin Technologies' overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Palatin Technologies (FRA:PTN), the current FCF Margin % is -112.65% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Palatin Technologies Business Description

Other Exchanges PTN:USA0KF3:UK
Address 103 Carnegie Center Drive, Suite 300, Princeton, NJ, USA, 08852
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.
19GF Score

Get the complete analysis for FRA:PTN

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.30
Price